TG Therapeutics data shows BRIUMVI reduces relapse rates in active MS patients

Go back to TG Therapeutics data shows BRIUMVI reduces relapse rates in active MS patients
TG THERAP (NASDAQ: TGTX) Delayed: 53.52 --0 (-0%)
Previous Close $53.52    52 Week High $14.87 
Open $53.52    52 Week Low $4.90 
Day High $53.52    P/E N/A 
Day Low $53.52    EPS $-0.67 
Volume 128